GOLDEN DEVELOPING SOLUTIONS, INC. Item 1.01. Entry into a Material Definitive Agreement.
On
Pursuant to the Settlement Agreement, the Company had issued a Senior Secured
Convertible Promissory Note to Leonite dated as of
The Parties settled the Company's obligations under the Note, Securities
Agreement, and Security and Pledge Agreement , including a balance due of one
hundred twenty-three thousand five hundred
1. The Company shall cause to be delivered to Leonite 62,000,000 shares of common stock (the "Settlement Shares"), in exchange for the Note, upon the following schedule with time being of the essence:
(a) 30,000,000 shares of common stock immediately but in no event more
than three (3) business days;
(b) The remainder of the shares of common stock in 30 days. Provided
however, that if the issuance of such shares would result in
beneficial ownership by Leonite and its affiliates of more than
4.99% of the outstanding Common Shares, then such issuance shall
be delayed until requested by Leonite. Notwithstanding the
preceding sentence, the limitations on conversion may be waived up
to a maximum of 9.99% by Leonite upon, at its election, not less
than 61 days' prior notice to Company. Furthermore, the provisions
of the conversion limitation shall continue to apply until such
61st day, or such later date, as determined by Leonite, as may be
specified in such notice of waiver.
2. Leonite had agreed that for a period of three months following the Effective Date, with regards to the Settlement Shares, Leonite shall be limited to selling, on each trading day, the greater of (i) 10% of the daily trading volume of the Company's ordinary shares; and (ii) 1,000,000 per day, subject to splits and adjustments, whichever is greater. The leak out amount shall accrue for each calendar day based on the volume on the last prior trading day and will be eligible to be sold on any subsequent day. Upon request, Leonite shall furnish daily trade dates within three (3) business days following such request.
3. Upon the initial issuance and the subsequent issuance of the Settlement Shares , the Outstanding Balance will be deemed to have been satisfied in full and Leonite shall terminate any UCC filings and provide a customary satisfaction letter upon request.
The Settlement Agreement includes customary general releases, representations, warranties and covenants by the respective parties.
The foregoing descriptions of the Settlement Agreement, Note and Securities Agreement are qualified in their entirety by reference to the Settlement Agreement, Note and Securities Agreement, copies of which are filed herewith as Exhibits 10.1, 10.2 and 10.3, respectively, and incorporated herein by reference.
2
Item 3.02. Unregistered Sales of
The disclosure set forth above in Item 1.01 of this Current Report on Form 8-K with respect to the Settlement Agreement is incorporated by reference in this Item 3.02. The Settlement Shares issued pursuant to the Settlement Agreement were not registered under the Securities Act of 1933, as amended (the "Securities Act"), and were issued in reliance on the exemption from registration requirements thereof provided by Section 4(a)(2) of the Securities Act.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.
Exhibit Description No. 10.1* Settlement and Exchange Agreement, datedOctober 20, 2022 , as between the registrant,Renaissance Health Publishing, LLC ,Renown Health LLC and Leonite Capital, LLC . 10.2* Senior Secured Convertible Promissory Note, datedMarch 16, 2021 , as between the registrantRenaissance Health Publishing, LLC ,Renown Health LLC and Leonite Capital, LLC. 10.3* Securities Purchase Agreement, datedMarch 16, 2021 , as between the registrant,Renaissance Health Publishing, LLC ,Renown Health LLC and Leonite Capital, LLC . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
* Furnished herewith.
© Edgar Online, source
